tiprankstipranks
Citius Pharmaceuticals (CTXR)
NASDAQ:CTXR

Citius Pharmaceuticals (CTXR) Stock Forecast & Price Target

1,171 Followers
See the Price Targets and Ratings of:

CTXR Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Citius
Pharmaceuticals
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CTXR Stock 12 Months Forecast

There Are No Analyst Ratings for CTXR In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

CTXR Financial Forecast

CTXR Earnings Forecast

Next quarter’s earnings estimate for CTXR is -$0.02 with a range of -$0.02 to -$0.02. The previous quarter’s EPS was -$0.06. CTXR beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.59% of the time in the same period. In the last calendar year CTXR has Underperformed its overall industry.
Next quarter’s earnings estimate for CTXR is -$0.02 with a range of -$0.02 to -$0.02. The previous quarter’s EPS was -$0.06. CTXR beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.59% of the time in the same period. In the last calendar year CTXR has Underperformed its overall industry.
No data currently available

CTXR Sales Forecast

Next quarter’s sales forecast for CTXR is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. CTXR beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.51% of the time in the same period. In the last calendar year CTXR has Underperformed its overall industry.
Next quarter’s sales forecast for CTXR is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. CTXR beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.51% of the time in the same period. In the last calendar year CTXR has Underperformed its overall industry.

CTXR Analyst Recommendation Trends

CTXR has not received any ratings in the last 3 months.
CTXR has not received any ratings in the last 3 months.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright
$4.00
Buy
417.46%
Upside
Reiterated
08/10/23
Analysts Are Bullish on These Healthcare Stocks: Citius Pharmaceuticals (CTXR), Aprea Therapeutics (APRE)
Maxim Group
$4.00
Buy
417.46%
Upside
Assigned
06/26/23
Analysts Offer Insights on Healthcare Companies: Citius Pharmaceuticals (CTXR) and Abcam (ABCM) - TipRanks.comMaxim Group analyst Michael Okunewitch maintained a Buy rating on Citius Pharmaceuticals yesterday and set a price target of $4.00 . The companys shares closed last Friday at $1.29.
Dawson James
$8.00
Buy
934.93%
Upside
Reiterated
05/04/23
Citius Pharmaceuticals (CTXR) PT Lowered to $8 at Dawson JamesDawson James analyst Jason Kolbert lowered the price target on Citius Pharmaceuticals (NASDAQ: CTXR) to $8.00 (from $10.00) while maintaining a Buy rating.

Best Analysts Covering Citius Pharmaceuticals

Which Analyst Should I Follow If I Want to Buy CTXR and Sell After:
1 Month
Jason KolbertDawson James
Success Rate
9/24 ratings generated profit
38%
Average Return
+4.72%
reiterated a buy rating 7 months ago
Copying Jason Kolbert's trades and holding each position for 1 Month would result in 37.50% of your transactions generating a profit, with an average return of +4.72% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Jason KolbertDawson James
Success Rate
9/24 ratings generated profit
38%
Average Return
+0.18%
reiterated a buy rating 7 months ago
Copying Jason Kolbert's trades and holding each position for 3 Months would result in 37.50% of your transactions generating a profit, with an average return of +0.18% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Jason KolbertDawson James
Success Rate
10/24 ratings generated profit
42%
Average Return
+4.95%
reiterated a buy rating 7 months ago
Copying Jason Kolbert's trades and holding each position for 1 Year would result in 41.67% of your transactions generating a profit, with an average return of +4.95% per trade.
2 Years
Jason KolbertDawson James
Success Rate
8/24 ratings generated profit
33%
Average Return
+4.17%
reiterated a buy rating 7 months ago
Copying Jason Kolbert's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of +4.17% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

CTXR Stock Forecast FAQ

What is CTXR’s average 12-month price target, according to analysts?
Currently, no data Available
What is CTXR’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CTXR, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is CTXR a Buy, Sell or Hold?
      Currently, no data Available
      What is Citius Pharmaceuticals’s price target?
      Currently, no data Available
      What do analysts say about Citius Pharmaceuticals?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of CTXR?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis